Skip to content

Prospective cohort study of patients with hypertrophic cardiomyopathy

Prospective cohort study of patients with hypertrophic cardiomyopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071129
Enrollment
Unknown
Registered
2023-05-05
Start date
2023-05-05
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic cardiomyopathy

Interventions

Sponsors

Second Affiliated Hospital of Army Medical University (Xinqiao Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years at inclusion; 2. Patients with maximal left ventricle wall thickness =15 mm measurement by echocardiography and/or cardiac magnetic resonance imaging or =13 mm for individuals with family history of HCM;3.Written, voluntary informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Patients with severe valvular heart disease,congenital heart disease,hypertensive heart disease or other cardiac or systemic diseases capable of producing left ventricle hypertrophy;2.Life expectancy less than 12 months;3.Without written informed consent.

Design outcomes

Primary

MeasureTime frame
All cause death, cardiovascular death and other adverse cardiovascular events;

Secondary

MeasureTime frame
Cardiac structural changes, peak oxygen consumption in cardiopulmonary exercise testing,NYHA cardiac functional class and admission for heart failure ;

Countries

China

Contacts

Public ContactZhexue Qin

Department of Cardiology, Xiaoqiao Hospital, Chongqing, China

zhexueqin@126.com+86 15823810730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026